New triple therapy takes on tough colorectal cancer
Disease control
Recruiting now
This phase II trial tests whether a combination of three drugs—balstilimab, botensilimab, and agenT-797—can shrink tumors in adults with a specific type of advanced colorectal cancer that has spread to the liver. All 17 participants will receive the treatment, and researchers wil…
Phase: PHASE2 • Sponsor: Darren Sigal, MD • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC